Brigham Young University

BYU ScholarsArchive
Theses and Dissertations
2009-07-08

The Role of SmpB in the Early Stages of Trans-Translation
DeAnna June Cazier
Brigham Young University - Provo

Follow this and additional works at: https://scholarsarchive.byu.edu/etd
Part of the Biochemistry Commons, and the Chemistry Commons

BYU ScholarsArchive Citation
Cazier, DeAnna June, "The Role of SmpB in the Early Stages of Trans-Translation" (2009). Theses and
Dissertations. 2126.
https://scholarsarchive.byu.edu/etd/2126

This Thesis is brought to you for free and open access by BYU ScholarsArchive. It has been accepted for inclusion
in Theses and Dissertations by an authorized administrator of BYU ScholarsArchive. For more information, please
contact scholarsarchive@byu.edu, ellen_amatangelo@byu.edu.

THE ROLE OF SMPB IN THE EARLY STAGES OF
TRANS-TRANSLATION

by
DeAnna June Cazier

A thesis submitted to the faculty of
Brigham Young University
in partial fulfillment of the requirements for the degree

Master of Science

Department of Chemistry and Biochemistry
Brigham Young University
August 2009

BRIGHAM YOUNG UNIVERSITY

GRADUATE COMMITTEE APPROVAL

of a thesis submitted by
DeAnna June Cazier
This thesis has been read by each member of the following graduate committee
and by majority vote has been found to be satisfactory.

_____________________________
Date

_________________________________
Allen R. Buskirk, Chair

_____________________________
Date

_________________________________
Barry M. Willardson

_____________________________
Date

_________________________________
Joel S. Griffitts

BRIGHAM YOUNG UNIVERSITY

As chair of the candidate’s graduate committee, I have read the thesis of DeAnna June
Cazier in its final form and have found that (1) its format, citations, and bibliographical
style are consistent and acceptable and fulfill university and department style
requirements; (2) its illustrative materials including figures, tables, and charts are in
place; and (3) the final manuscript is satisfactory to the graduate committee and is ready
for submission to the university library.

___________________________
Date

___________________________________
Allen R. Buskirk
Chair, Graduate Committee

Accepted for the Department

__________________________
Date

____________________________________
Paul B. Farnsworth
Department Chair

Accepted for the College

__________________________
Date

____________________________________
Thomas W. Sederberg
Associate Dean
College of Physical and Mathematical Sciences

ABSTRACT

THE ROLE OF SMPB IN THE EARLY STAGES OF
TRANS-TRANSLATION

DeAnna June Cazier
Department of Chemistry and Biochemistry
Master of Science

Ribosomes stall on defective messenger RNA transcripts in eubacteria. Without a
mechanism to release stalled ribosomes, these cells would die. Transfer-messenger RNA
(tmRNA) and small protein B (SmpB) reactivate stalled ribosomes in a process known as
trans-translation. Together, tmRNA and SmpB mimic alanyl-tRNA, entering the A site
of stalled ribosomes and accepting transfer of the stalled polypeptide. A portion of
tmRNA is then positioned as a template for the ribosome to resume translating. The
tmRNA open reading frame encodes a proteolysis tag to mark the aberrant polypeptide
for degradation and a stop codon to release the ribosome.
How are tmRNA and SmpB allowed into stalled ribosomes? In normal
translation, decoding mechanisms carefully monitor the anticodon of tRNAs entering the
A site and select only those that are complementary to the mRNA codon. How do

tmRNA and SmpB get around the decoding machinery? It appears that interactions
between the SmpB C-terminal tail and the decoding center are responsible. Using an in
vivo tagging assay and an in vitro peptidyl-transfer assay, we monitored the effect of
mutations in the SmpB tail on trans-translation. We found that mutations in SmpB that
prevent helix formation are unable to support peptidyl transfer. We also found that while
mutation of key nucleotides in the ribosomal decoding center severely inhibit peptidyl
transfer to normal tRNAs, these mutations do not inhibit peptidyl transfer to tmRNA. We
conclude that the SmpB tail stimulates peptidyl transfer by forming a helix that interacts
with the ribosome to signal decoding in a novel manner.
How is the tmRNA open reading frame positioned for the ribosome to resume
translating? Mutation of the tmRNA nucleotide A86 alters reading frame selection.
Using a genetic selection, we identified SmpB mutants that restore normal frame
selection to A86C tmRNA without altering frame selection on wild-type tmRNA.
Through rational mutation of the SmpB tail we identified an SmpB mutant that supports
peptidyl transfer but prevents translation of the tmRNA open reading frame. We
conclude that SmpB plays a functional role in selecting the tmRNA open reading frame.
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CHAPTER 1: INTRODUCTION

The Ribosome and Translation
Ribosomes convert genetic information (encoded in nucleic acids) into a functional
form (proteins). Cells cannot survive without functioning ribosomes. Many antibiotics kill
bacteria by binding to the ribosome and preventing protein synthesis. Depleting or
sequestering ribosomes results in cell death.
Bacterial ribosomes are composed of a large (50S) subunit and a small (30S) subunit.
In E. coli, the large subunit contains thirty-six proteins and the 23S and 5S ribosomal RNAs
(rRNAs). The small subunit is composed of twenty-one proteins and the 16S rRNA. The
proteins in both subunits are found mostly on the outer surfaces while the rRNAs occupy the
interior.1, 2
Each subunit plays a different role in
translation. The small subunit has a decoding
center that selects tRNAs by monitoring the
pairing of an mRNA codon with a tRNA
anticodon. The large subunit contains a
peptidyl-transferase center where peptide
bonds are formed and a GTPase associated
center (GAC) where proteins bind to
Figure 1-1: Crystal structure of a Thermus
thermophilus 70S ribosome with tRNAs in the A
site, P site and E site bound to an mRNA (green).
From Korostelev, A.; Ermolenko, D. N.; Noller, H.
F., Structural dynamics of the ribosome. Curr
Opin Chem Biol 2008, 12 (6), 674-83. Reprinted
with permission from Elsevier.
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facilitate various steps in translation. The
two subunits come together on an mRNA
template to form a functional 70S ribosome

(Figure 1-1).
There are three tRNA binding sites in a 70S ribosome: the aminoacyl or A site, the
peptidyl or P site, and the exit or E site. During its transit of the ribosome, a tRNA will
occupy each of these binding sites. The A site selects cognate or complimentary tRNAs to
enter the ribosome. The P site holds the tRNA while it is bound to the nascent polypeptide
chain. The E site ejects deacylated tRNAs from the ribosome to be recycled.
Translation by the ribosome is separated into three steps: initiation, elongation and
termination. Prokaryotic initiation begins by positioning an mRNA start codon and its
cognate tRNA in the P site of the 30S subunit. Three initiation factors bind the 30S subunit
to aid in the initiation process. IF-3 binds the E site and prevents premature association of
the 50S subunit. IF-1 binds near the decoding center in the A site to prevent tRNAs from
interacting. IF-2 brings the initiator fMet-tRNA to the small subunit and positions it in the P
site where it will pair with the mRNA start codon. An mRNA template binds directly to the
30S via its ribosome binding site (RBS) or Shine-Dalgarno sequence. Complimentary
pairing between the RBS and the 16S rRNA positions the start codon in the 30S P site. The
start codon is further situated by binding to the initiator tRNA. Once all of these factors are
properly positioned on the small subunit, IF-3 dissociates and the 50S subunit binds. Binding
of the 50S triggers GTP hydrolysis by IF-2, which releases both IF-1 and IF-2 from the small
subunit. The 70S initiation complex is now fully assembled on an mRNA template with a
tRNA in the P site.3
Once the 70S initiation complex is formed, the ribosome begins elongating the
peptide chain one amino acid at a time. Elongation is a repetitive cycle of tRNA selection,
peptidyl transfer and translocation. During tRNA selection, many different aminoacylated
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tRNAs diffuse in and out of the A site. Each tRNA is bound near its 3′ terminus by
elongation factor-Tu (EF-Tu) and GTP. The decoding center checks the pairing of the
anticodon of each entering tRNA with the mRNA codon in the A site. Cognate tRNAs are
selected to remain in the A site and noncognate tRNAs are rejected. Selection of a tRNA
involves conformational changes in both the ribosome and the tRNA that activate EF-Tu.
Activated EF-Tu hydrolyzes GTP and dissociates from the ribosome. This allows the tRNA
to rotate and become fully accommodated in the A site.4
Following accommodation, the peptidyl-transferase center catalyzes the formation of
a peptide bond between the amino acid on the A-site tRNA and the nascent polypeptide chain
attached to the P-site tRNA. The ribosome catalyzes the amide bond formation through
positioning of the two tRNAs. The ribosome reduces the entropic cost by positioning the Asite and P-site tRNAs such that their attached amino acids are in close proximity.5
Additionally, the P-site tRNA is oriented with the 2′-OH on A76 to act as a proton shuttle in
the reaction.6 With the tRNAs in place, the peptide chain on the P-site tRNA is transferred
onto the A-site amino acid, leaving an uncharged tRNA in the P site.
Translocation moves the peptide chain back into the P site and brings the next mRNA
codon into the A site. This rearrangement is driven by elongation factor-G (EF-G), a GTPase
that binds the ribosome following peptidyl transfer. Hydrolysis of GTP results in an EF-G
conformational change that pushes the A-site peptidyl-tRNA and the mRNA codon to which
it is bound into the P site. EF-G•GDP dissociates from the ribosome, leaving only an mRNA
codon in the A site.7 The cycle of tRNA selection, peptidyl transfer, and translocation is
repeated until an mRNA stop codon enters the A site.
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A stop codon signals translational termination by recruiting a class I release factor,
RF1 or RF2. RF1 binds the stop codons UAG and UAA, while RF-2 binds UGA and UAA.
Class I release factors stimulate transfer of the nascent peptide chain onto a water molecule,
liberating it from the ribosome. Once the polypeptide has been released, the class II release
factor RF3 binds the class I release factor and both dissociate from the ribosome. Ribosome
recycling factor (RRF) and EF-G then separate the ribosome back into two separate subunits.
IF-3 binds the small subunit to prevent reassociation with the large subunit until a new
mRNA template has been bound and positioned for translation.8

Ribosome Stalling
Ribosomes become stalled if they are unable to complete the steps of elongation or
termination. The use of the term “stall” in the literature is ambigious. It may refer to a
temporary pause in translation that can be reversed, or it may refer to arrested ribosomes that
are unable to resume translating or be released from their mRNA template by canonical
means. We will use the term to mean irreversibly arrested. Ribosomes can be stalled
indirectly through a lack of resources or directly by the binding of inhibitory molecules.
Some mRNAs cause ribosome stalling because they do not have a stop codon.
Without a stop codon, the ribosome translates to the 3′ end of the mRNA where it cannot be
released by release factors. Since transcription and translation occur simultaneously in
bacteria, an mRNA can lose its stop codon before or after a ribosome begins translating.
Some mRNAs are made without stop codons due to transcriptional errors. Premature
termination of RNA polymerase results in nonstop mRNAs.9 Additionally, bacterial
exonucleases degrade RNA in a 3′-5′ direction, creating nonstop mRNAs by destroying the
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mRNA stop codon on actively translating templates. Whatever their source, mRNAs that
lack a stop codon stall ribosomes.
An mRNA that contains consecutive rare codons can also lead to ribosome stalling.
Not all tRNAs are equally abundant in the cell. Rare mRNA codons call for tRNAs
expressed at low levels. When the ribosome encounters a rare codon it pauses until the
cognate tRNA is found. Most often the tRNA binds after a brief pause and the ribosome
continues normal translation. However, a string of several rare codons in a row pauses the
ribosome for so long that the downstream mRNA can become cleaved or degraded back to
the stalled ribosome, creating a nonstop mRNA.10
Interestingly, a few nascent peptide sequences stall ribosomes even when the mRNA
template has a stop codon and tRNAs are abundant. Peptide stalling sequences directly
inhibit function of the ribosome by binding the peptidyl-transferase center or the peptide exit
tunnel. SecM and TnaC are two bacterial leader peptides that stall ribosomes and regulate
the expression of downstream genes.11, 12 The genes downstream of SecM and TnaC are only
expressed when the ribosome is paused on the leader peptide sequence. The downstream
gene product releases the stalled ribosome, thereby downregulating its own synthesis.
Because ribosomes stalled on such leader peptides are released, regulatory stalling events are
reversible and are therefore better thought of as pausing events rather than truly arrested
ribosomes that require rescuing.
Non-regulatory nascent peptide stalling sequences have also been discovered. GluPro-Stop at the C-terminus of any protein causes the ribosome to stall irreversibly.13 The Psite proline appears to be the greatest contributor to stalling in this sequence. Replacing it
with the structurally similar molecule azetidine-2-carboxylic acid decreases stalling, while
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exchanging the proline for 3,4 dehydroproline increases stalling. The glutamate also
contributes to ribosome inhibition, and mutation to an amino acid other than aspartate or
proline drastically reduces stalling. Since Glu-Pro-Stop is too short to make contacts with
the exit tunnel, the dipeptide most likely inhibits the peptidyl-transferase center directly or
interferes with termination machinery binding to the A-site stop codon.13
Irreversibly stalled ribosomes are a problem to the cell for several reasons. Multiple
ribosomes will accumulate on a single mRNA, decreasing the pool of ribosomes available to
translate needed proteins. In E. coli ribosomes stall so frequently that if there were no way to
rescue them, all ribosomes would be stalled in a single generation and the cell would die.14
On the other hand if stalled ribosomes are rescued, the released abnormal peptide could be
toxic to the cell. Also, the mRNA that caused stalling can continue to stall other ribosomes
until it is fully degraded. In order to survive, cells need a mechanism to rescue and recycle
stalled ribosomes.

Trans-translation Overview
Rather than abandoning stalled ribosomes, bacteria have evolved a way to reactivate
them. The two molecules responsible for this, transfer-messenger RNA (tmRNA) and small
protein B (SmpB), are conserved among all eubacteria. Together SmpB and tmRNA
facilitate template swapping on stalled ribosomes. The old nonfunctional mRNA is ejected
from the ribosome and a portion of tmRNA is positioned in the ribosome as a new template.
The tmRNA open reading frame ends in a stop codon, enabling the ribosome to be released
normally. This process is known as trans-translation.14
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tmRNA has two distinct domains which enable it
to act as both a tRNA and an mRNA during transtranslation (Figure 1-2).15 The tRNA-like domain (TLD)
is aminoacylated with alanine and enters the A site to
accept transfer of the stalled peptide. Following
translocation of the TLD to the P site, the first codon in
the mRNA like portion of tmRNA is positioned in the A
site. This enables the ribosome to resume translating on
tmRNA using the normal elongation cycle. The short
Figure 1-2: Secondary structure of
tmRNA. The first and last codons of
the open reading frame are boxed.
PK stands for pseudoknot.

mRNA-like domain encodes a protease recognition
sequence (ANDENYALAA in E. coli). A stop codon at
the end of this sequence allows the ribosome to release

the tagged peptide and dissociate from tmRNA. Using both the tRNA and mRNA-like
domains of tmRNA, the ribosome makes one protein from two templates.14
SmpB is essential for all known functions of tmRNA.16 The beta barrel core of SmpB
binds the TLD of tmRNA with high affinity and specificity.17, 18 Binding of SmpB to
tmRNA protects both molecules from degradation and enhances tmRNA aminoacylation
with alanine.19-21 SmpB facilitates tmRNA entry into stalled ribosomes.20, 22 SmpB has a Cterminal tail of 30 amino acids in E. coli. This tail is unstructured in solution but is required
for transfer of the stalled peptide onto tmRNA.23
Together tmRNA and SmpB resolve all three problems associated with stalled
ribosomes. Most importantly, tmRNA and SmpB release stalled ribosomes from their
template mRNAs and return them to the pool of active ribosomes. Secondly, the aberrant
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peptide has a protease recognition sequence added to its carboxy terminus. This targets the
potentially toxic peptide for degradation once it is released from the ribosome. Finally, the
troublesome mRNA is ejected from the ribosome and degraded in a tmRNA dependent
manner.24

In the A site
How do tmRNA and SmpB mimic a tRNA to enter the ribosomal A site? In normal
translation, cognate tRNAs are selected by the ribosome using induced-fit and kinetic
proofreading mechanisms involving the decoding center of the 30S A site. These two
mechanisms are incorporated into a kinetic model of decoding which includes both the initial
selection of the tRNA and its accommodation into the A site (Figure 1-3).25 tRNA selection
and accommodation are irreversibly separated by GTP hydrolysis. Induced fit accelerates
both the forward rate of EF-Tu activation before GTP hydrolysis (k3), and accommodation of
the tRNA following GTP hydrolysis (k5). Noncognate tRNAs have faster rates of
dissociation from the ribosome before and after GTP hydrolysis (k–2 and k7) than cognate
tRNAs, which proceed more rapidly towards peptidyl transfer (k3 and k5).

Figure 1-3: Kinetic model of decoding. From Cochella, L.; Green, R., An active role for tRNA in
decoding beyond codon:anticodon pairing. Science 2005, 308 (5725), 1178-80. Reprinted with
permission from AAAS.
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Initial tRNA selection depends on pairing of the codon and anticodon. As different
tRNAs diffuse in and out of the A site, tRNAs that form noncognate codon-anticodon
interactions dissociate quickly (k–1) while a tRNA bound to its cognate remains in the A site
longer. If the tRNA remains in the ribosome long enough, both the ribosome and the tRNA
will undergo conformational changes to check pairing of the codon-anticodon.
A tRNA has to be deformed to bind both the codon in the small ribosomal subunit
and EF-Tu in the large ribosomal subunit. A tRNA binding its cognate codon is stabilized by
the ribosome in this strained state, whereas a noncognate interaction is not. Stabilization
leads to a decreased dissociation of the tRNA from the ribosome (k–2). This is the tRNA role
in induced fit.25
The ribosome also undergoes conformational changes to check for correct pairing of
the codon-anticodon. Ribosomal nucleotides A1492, A1493 and G530 check the accuracy of
pairing between the codon and anticodon in the small subunit.26 A1492 and A1493 flip out
of ribosomal helix 44 and make minor groove interactions with the first two base pairs of the
codon-anticodon. A1492 and A1493 act as calipers that only interact in the minor groove if
the codon-anticodon bases are Watson-Crick paired.26 G530 rotates to interact with the third
base pair. This interaction is not as rigid and wobble pairing at the third position is
allowed.26 If the ribosomal nucleotides cannot make the proper interactions with the codonanticodon helix, the noncognate tRNA more readily dissociates (k–2). For cognate
interactions, these seemingly small movements in ribosomal nucleotides lead to a rotation of
the head and shoulder of the 30S subunit, bringing the ribosome into a more closed
conformation around the codon-anticodon. This closed conformation holds the tRNA more
tightly in the A site.
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Following initial tRNA selection, GTP hydrolysis occurs. Deformation of the tRNA
and domain closure of the ribosome both contribute to activation of EF-Tu (k3) which
hydrolyzes GTP (kGTP).25 GTP hydrolysis separates tRNA selection from accommodation.
During accommodation, the 3'-aminoacylated end of tRNA moves almost 70 Å from EF-Tu
to the peptidyl-transferase center. In this step noncognate tRNAs dissociate from the
ribosome at a much higher rate (k7) than cognate tRNAs (k5). This is the final check for
correct pairing of the codon-anticodon before the peptide bond is formed. The actual
chemistry of peptide bond formation occurs very rapidly (kpep), with accommodation being
the rate limiting step in the whole process.
Since there is no codon-anticodon interaction when SmpB and tmRNA first enter
stalled ribosomes, how does this complex trigger transfer of the stalled polypeptide onto the
tmRNA alanine? Although tmRNA has a tRNA like domain (TLD), it is missing the
anticodon stem. An x-ray crystal structure of the TLD bound to SmpB shows the body of
SmpB replacing the missing stem (Figure 1-4).27 Although the C-terminal SmpB tail is

Figure 1-4: Molecular mimicry of tmRNA and SmpB. The TLD of tmRNA is shown in dark blue,
Phe
and SmpB with the C terminal tail truncated is in light blue. In red is the structure of a tRNA
Ser
from yeast and in green is a tRNA
from T. Thermophilus. From Bessho, Y.; Shibata, R.;
Sekine, S.; Murayama, K.; Higashijima, K.; Hori-Takemoto, C.; Shirouzu, M.; Kuramitsu, S.;
Yokoyama, S., Structural basis for functional mimicry of long-variable-arm tRNA by transfermessenger RNA. Proc Natl Acad Sci U S A 2007, 104 (20), 8293-8. Reprinted with permission
from PNAS.
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truncated in the crystal structure, the beginning of the tail is positioned in such a way that the
missing amino acids could interact with the ribosomal decoding center. Cryo-EM data of an
EF-Tu-tmRNA-SmpB entry complex in the A site of a 70S ribosome also places the Cterminal tail of SmpB in the decoding center.28
Where does SmpB contact the ribosome? When added to empty 70S ribosomes,
SmpB protects nucleotides in the small subunit P site and E site from chemical modification.
The location of protected nucleotides corresponds to where the anticodon stem loop of a
tRNA interacts during normal transit of the ribosome.29 Directed hydroxyl radical probing
studies of SmpB in stalled ribosomes (vacant A site only) reveal additional SmpB-ribosome
interactions. Fe(II)-BABE produces hydroxyl radicals when Fe(II) is oxidized to Fe(III). By
tethering Fe(II)-BABE to specific loci on SmpB, hydroxyl radicals can be produced at
discrete locations in the presence of Fe(II) oxidizing agents. Fe(II)-BABE tethered to SmpB
inside a stalled ribosome produces hydroxyl radicals that cleave ribosomal RNA immediately
surrounding the Fe-BABE moiety. The position of rRNA cleavages maps the SmpB tail in
the A site near the decoding center and along the mRNA downstream path.30 SmpB can
occupy each of the three tRNA binding sites in the ribosome.
Recently, Felden and co-workers suggested that the SmpB tail interacts directly with
the A site nucleotides critical for normal translation: A1492, A1493 and G530.31 To study a
possible interaction between SmpB and these nucleotides, authors used nuclear magnetic
resonance (NMR) techniques and a ribosomal A site mimic. An A site mimic is a short RNA
stem loop corresponding to the 16S ribosomal helix 44. Helix 44 is part of the 30S decoding
center and contains A1492 and A1493. The authors showed a change in resonance for
nucleotides A1492 and A1493 when placed in solution with an SmpB-TLD complex.
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Similarly, specific SmpB residues had altered NMR signals when placed in solution with the
A site mimic. From these results, authors conclude that SmpB interacts with A1492 and
A1493 following SmpB entry into the A site.31
Combining the structural information, it appears that SmpB interacts with the
ribosome to replace a missing codon-anticodon interaction. Are interactions between SmpB
and the ribosome sufficient to signal for peptidyl transfer or is the body of tmRNA
functionally required? Shimizu and co-workers tested the involvement of tmRNA in peptidyl
transfer by making a truncated tmRNA with only the aminoacylated TLD. When bound by
SmpB, the TLD accepts transfer of the stalled peptide. Stalled ribosomes incubated with
TLD-SmpB complexes cycle through multiple TLD-SmpBs and have polyalanine added to
the stalled peptide.32 The body of tmRNA does not contribute to decoding center trickery.
How does SmpB signal for peptidyl transfer to occur? Karzai and colleagues
truncated the E. coli SmpB tail (Ala130-Arg160) at various lengths and tested the proteins
ability to support peptidyl transfer.23 They discovered that deleting residues 154-160 (∆153)
eliminates transfer of alanine onto stalled peptides. They also found that mutation of the
highly conserved tail sequence D137KR to A137AA abolished peptidyl transfer. Neither of the
inactive SmpB mutants was defective in binding to tmRNA or promoting its association with
stalled 70S ribosomes. The authors concluded that D137KR and I154M functionally interact
with the ribosome to signal for peptidyl transfer.23 They further suggest that the SmpB tail
could acquire structure in the A site to position these two regions. Others have also proposed
that the SmpB tail forms a structure inside the ribosome. Based on the regular occurrence of
basic amino acids in the SmpB tail33 and the periodical cleavage pattern of Fe-BABEgenerated hydroxyl radicals,30 the SmpB tail may form a helix in the A site.
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Although much has been discovered about how tmRNA and SmpB trigger the
decoding center into allowing peptidyl transfer of the stalled peptide onto tmRNA, there are
still unanswered questions. Does the deformability of tmRNA influence peptidyl transfer?
Do other amino acids in the SmpB tail functionally interact with the ribosome? Does the
SmpB tail acquire a helical structure in the A site that is important for peptidyl transfer? Are
ribosomal nucleotides A1492 and A1493 functionally involved in the first decoding event in
trans-translation? In Chapter 2 we offer insight into the last two questions.

Frame Selection in the P site
Following peptidyl transfer and translocation, the ribosome resumes translating on the
tmRNA open reading frame (ORF). Amazingly, the ribosome proceeds with translation at the
tmRNA resume codon as if there had been no break between templates. If the ribosome
began translating even one nucleotide away from the resume codon, the proteolysis tag and
the stop codon would be missed. With hundreds of nucleotides in tmRNA, how do stalled
ribosomes consistently resume translation at the same spot?
Four pseudoknots dominate the structure of tmRNA. Since the pseudoknots clearly
position the tmRNA ORF globally, could they also determine precisely where translation
resumes on tmRNA? All four psuedoknots have been altered or deleted singly and in
combination without disrupting tmRNA function.34-36 This suggests that the tmRNA
pseudoknots do not directly position the resume codon in the ribosomal A site.
A likely candidate for positioning the resume codon correctly in the ribosome is the
resume codon itself. Williams et. al tested this theory by mutating the resume codon to
encode a variety of different amino acids. Neither the resume codon sequence nor the amino
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acid residue encoded affected frame selection.37 This indicates that the resume codon does
not bind the ribosome directly and a specific tRNA is not binding the resume codon sequence
to position it in the A site. It appears that something other than the resume codon is
responsible for its positioning in the A site.
The nucleotides upstream of the resume codon (Figure 1-5) were also implicated in
precisely determining the tmRNA translation frame.37, 38 Deletion of any one nucleotide
from U85 to C89 results in translation of a mixture of frames.39 Several nucleotide mutations
in this region cause the ribosome to resume translating in the –1 frame. U85A causes the
greatest –1 shift in frame selection, with the ribosome resuming at position 89 instead of 90
approximately 45% of the time.39 Four nucleotides upstream of the resume codon is a
universally conserved adenine.40
Mutation of A86 to either a U or a C
results in resuming translation exclusively
in the +1 frame.38, 39 The five nucleotides
upstream of the resume codon play a
Figure 1-5: Sequence logo displaying the tmRNA
upstream consensus of all 555 known tmRNA
sequences. Created by Weblogo. Crooks, G. E.; Hon,
G.; Chandonia, J. M.; Brenner, S. E., WebLogo: a
sequence logo generator. Genome Res 2004, 14 (6),
1188-90.

significant role in the ribosomal selection
of frame on tmRNA.
How do these nucleotides position

the resume codon? Lim and Garber proposed that the three nucleotides immediately
upstream of the resume codon, called the –1 triplet, bind the ribosome directly.41 From
computational analysis they determined that the –1 triplet could attain an A-form
conformation and bind the ribosome prior to transfer of the stalled peptide onto tmRNA.
Then when tmRNA translocates to the P site, the –1 triplet would go with it, leaving the
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resume codon in the A site. Based on this hypothesis they developed a set of rules defining
the allowed and forbidden –1 triplet sequences. All of the natural tmRNA –1 triplets fit their
rules.41 However, functional assays on all 64 possible –1 triplets gave results which did not
support these rules and pointed instead to the nucleotides further upstream, specifically U85
and A86, as important in setting the frame.38 Although these results discredited the –1 triplet
theory, there was still no direct evidence of how U85 and A86 would position the resume
codon in the A site after translocation.
One possibility is that a trans-acting factor binds the tmRNA upstream region to
position the resume codon. Two factors have been shown to bind the upstream region of
tmRNA in vitro: one of them is the ribosomal protein S1.42, 43 The functional requirement for
S1 in trans-translation has been debated in vitro.44-46 Thus far in vivo it appears that transtranslation has little or no functional requirement for S1.47
SmpB has been shown to protect the upstream region of tmRNA from modification in
some studies,48, 49 but not in others.19, 50 One recent study based on filter binding assays
claims that SmpB binds the upstream region of tmRNA more tightly than it binds the TLD.51
Perhaps the interaction between SmpB and the upstream region of tmRNA is transient or salt
dependent, making it hard to detect. Despite the differences in detecting this interaction,
Konno and colleagues show a shift in protection by SmpB on tmRNA mutants that are
known to cause frameshifting.48 Under their conditions, SmpB protects nucleotide U85 from
modification. The mutation A86U, which causes translation to resume in the +1 frame,
moves SmpB protection from position 85 to 86. Similarly, A84U/U85G resumes translation
in the –1 frame and is protected at position 84 instead of 85.48 SmpB remains a likely
candidate for interacting with the upstream region of tmRNA to position the resume codon.
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Using a genetic screen to rescue an A86C frameshifting tmRNA mutant, we provide
the first in vivo evidence that SmpB plays a functional role in setting the frame on tmRNA.
We also give an example of wild-type tmRNA paired with an SmpB mutant that can undergo
peptidyl transfer but not resume translating any part of the tmRNA ORF. This previously
uncharacterized role for SmpB is further evidence that SmpB is involved in positioning
tmRNA in such a way that the ORF can be translated.
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CHAPTER 2: THE ROLE OF SMPB IN THE A SITE

Unpublished work done in collaboration with Dr. Zhu Liu and the Rachel Green laboratory at
John Hopkins University School of Medicine.
Introduction
Bacteria possess a conserved translational quality control system with two main
components, small protein B (SmpB) and transfer-messenger RNA (tmRNA). tmRNA has
both a tRNA like domain that is aminoacylated with alanine and an mRNA like domain that
encodes a proteolysis tag. tmRNA and SmpB recognize stalled ribosomes on truncated or
damaged mRNAs and enter the A site, where the stalled peptide is transferred onto the
tmRNA alanine. Following translocation to the P site, the open reading frame of tmRNA is
positioned in the A site such that the ribosome can resume translating. At the end of the
short open reading frame, a stop codon signals for the ribosome to terminate translation
normally. The ribosome is released to translate other mRNAs and the tmRNA-tagged protein
is recognized by proteases and degraded.14, 52
How tmRNA and SmpB trick the ribosome into allowing peptidyl transfer onto
tmRNA is unclear. Canonical peptidyl transfer is preceded by the correct pairing of a tRNA
anticodon with an mRNA codon. Although tmRNA partially mimics a tRNA, it has no
anticodon loop. Furthermore the body of tmRNA does not compensate for the missing
anticodon; tmRNA can be truncated to contain only the tRNA-like domain and still undergo
peptidyl transfer.32 Structural data show SmpB poised to replace the missing tRNA
anticodon and interact with the decoding center.27, 28 Hydroxyl radical probing and
footprinting experiments have detected interactions of SmpB with ribosomal RNA in the A
site.30, 31
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There is some speculation about how the SmpB tail triggers peptidyl transfer.
Although unstructured in solution, several authors have proposed that the SmpB tail (residues
130-160 in E. coli) forms a structure in the A site to position amino acid residues that would
stimulate peptidyl transfer.23, 30, 33 E. coli tail residues D137KR and I154M are required for
peptidyl transfer. Mutating these sequences to alanine or truncating the tail before Ile154
eliminates peptidyl transfer.23 How and where these amino acid sequences interact with the
ribosome has not been determined.
Other amino acids at the beginning of the SmpB tail have been implicated in making
direct interactions with ribosomal decoding center nucleotides A1492 and A1493. These
nucleotides are crucial to the canonical decoding process.53 However, the SmpB-decoding
center interaction was detected using an A site mimic and not a 70S ribosome. The
functional relevance of the interaction has not been tested.
In this chapter we present several new findings that expand our understanding of the
mechanism of trans-translation. First, the SmpB tail forms a helix inside the ribosome that is
essential for peptidyl transfer. Second, the beginning of the SmpB tail plays an essential role
in trans-translation after peptidyl transfer but before translation of the tmRNA open reading
frame begins. Third, ribosomal nucleotides A1492 and A1493 are not significantly involved
in the first peptidyl-transfer event.

Results
Functional relevance of conserved residues in the C-terminal tail
The SmpB tail has several highly conserved amino acid residues (Figure 2-1). Based
on sequence alignment, we tested the functional relevance of the conserved residues
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K131GKK, D137KR, K143,
R145, and R153 in transtranslation. We used an in
vivo tmRNA tagging assay
to monitor the effects of
SmpB mutations on transtranslation. Full length
GST with a stalling
Figure 2-1: Conservation of amino acid residues in the SmpB C-terminal
40
tail. Generated by Weblogo. The height of each symbol indicates the
conservation of the amino acid at that position. The E. coli residue
number and sequence are printed below. The last two E. coli residues,
H159R, are not shown.

sequence at the C terminus
(Glu-Pro-Stop) is
overexpressed as a substrate

for tmRNA-mediated tagging. By mutating the tmRNA open reading frame to encode a His6
epitope, tagging of GST can be visualized on an immunoblot. GST expression is also
visualized and shown as a loading control. Expressing these modified constructs in
combination with wild-type or mutant SmpB allows us to determine the relative activity of
trans-translation.
The residues at the beginning of the SmpB tail, K131GKK, were recently implicated in
directly interacting with the ribosome decoding center.31 To test the functional importance of
these amino acid residues, we individually mutated each amino acid to alanine and monitored
tagging levels. No effect was seen except for an approximately two-fold decrease in tagging
with Gly132Ala. Mutating two lysines to alanine together reduced tagging significantly, as
in K131GAA and A131GAK. Mutating all three lysines to alanine at once, A131GAA,
abolished tagging. Interestingly, mutating glycine and only one lysine to alanine, K131AAK,

19

also eliminated tagging (Figure 2-2). We refer to this mutant as G132K:AA throughout the
rest of the paper.
Another highly conserved
W

K
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K
A
K
K A
K
T AGK K A K GA KGK K A A AGA KGA AGA
K

anti-His6

region of the SmpB tail, D137KR,
was previously shown to be

anti-GST

essential for tmRNA mediated

Figure 2-2: The effect of mutations in the SmpB sequence
K131GKK on tmRNA-mediated tagging.

tagging.23 While some mutation of
the amino acid sequence is tolerated,

changing all three residues to alanine, D137KR:AAA, abolishes tagging. As expected, no
detectable level of tagging is supported by the D137KR:AAA mutant in our immunoblot assay
(Figure 2-3).
The SmpB tail also has several conserved basic residues further downstream of
K131GKK and D137KR. Residues 143, 145, 149 and 153 are conserved as amino acids with
positively charged side chains in many SmpB proteins. In E. coli, only three of these basic
residues are preserved as Lys143, Arg145, and Arg153. We tested the functional relevance
of these positive charges by again mutating them to alanine individually or in combination
and monitoring tagging levels in immunoblots. When all three charges were removed, no
tmRNA mediated tagging was detected. When only two charges were removed, Lys143Ala

Figure 2-3: Immunoblot of tmRNAmediated tagging on a GST substrate.
SmpB mutants are labeled in each
lane. Nonfunctional SmpB mutants do
not support tagging of GST.
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and Arg145Ala, there was no effect on tagging. Arg153Ala by itself also produced no defect
in tagging (Figure 2-3).

The C-terminal tail functions as a helix
The periodicity of basic residues in the SmpB tail led to the hypothesis that once
inside the ribosome, the tail could form a helix.33 This hypothesis is supported by others who
see a periodical footprinting pattern of the SmpB tail in the ribosomal A site.30 We used a
software analysis program (JPred) to predict whether or not the tail of E. coli SmpB forms a
helix. According to JPred, a helix is likely to span approximately residues 142-157.
To test the functional relevance of a helical tail in trans-translation, we did an in vivo
proline scanning experiment. Various SmpB residues from 135-154 were mutated to proline
individually and tmRNA tagging activity monitored by immunoblot. Each amino acid
mutated to proline was also mutated to alanine as a control to show that the specific amino
acid lost was not important, just the ability of the tail to form a helix. We started proline
scanning upstream of the predicted helix but did not go past residue 154, since residues 155
and beyond can be deleted without negatively affecting tagging.23
While some proline mutations had little effect on tagging, introducing a proline into
the tail at or after Lys143 greatly decreases trans-translation efficiency (Figure 2-4). SmpB
mutants Gln135Pro and
T

anti-His6

W

la P A
P 1P P 5P
P A
35 D14 K143 R14 bl A 148 148 151 K151 154P 154A
1
D Q Q
I
I
K
Q

Asp141Pro support tagging
levels comparable to wild-type

anti-GST

Figure 2-4: Proline mutations in the SmpB tail and their effect on
tmRNA mediated tagging visualized by immunoblot. Dbl Ala refers to
the K143A/R145A control. This mutant is also shown in Figure 2-3.
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SmpB. However, Lys143Pro,
Arg145Pro, Lys151Pro, and

Ile154Pro yielded only negligible amounts of tagging and Gln148Pro was noticeably
reduced. The alanine controls for these mutations all support tagging without any defect.
These data indicate that the SmpB tail does form a helix inside the ribosome, and the
structure is functionally important during some step in trans-translation.

Tail residues required for accommodation
Next we set out to determine at which step in trans-translation these various SmpB
mutants have a defect. Two major roles for SmpB are binding to tmRNA and the ribosome.
It is possible that our mutants are defective in binding to one or both of these. However,
almost the entire SmpB tail can be truncated (up to Gly132) without decreasing the binding
affinity of SmpB for tmRNA or the ribosome.23 Although the tail may form functional
interactions with the ribosome and/or tmRNA to signal for peptidyl transfer, these
interactions do not contribute much to overall binding affinity. Since the mutations we found
all fall in the area of the SmpB tail which can be truncated and still bind, we think it unlikely
that mutation of one or two of these amino acids would significantly decrease binding.
Another known role for SmpB is supporting peptidyl transfer of the stalled peptide
onto Ala-tmRNA. We used an in vitro peptidyl-transfer assay to determine the efficiency of
various SmpB mutants in supporting dipeptide formation. Stalled ribosome initiation
complexes were prepared with a 35S labeled fMet-tRNA in the P site. Initiation complexes
were incubated with either wild-type or mutant SmpB in Ala-tmRNA-SmpB-EF-Tu•GTP
complexes and quenched at various timepoints by addition of potassium hydroxide. Products
were separated on an electrophoretic TLC and visualized by audioradiography. The fMetAla signal compared to total signal gives the percent yield of dipeptide formation.
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Although we used a 10-fold excess of tmRNA complexes in our peptidyl transfer
reactions, Ala-tmRNA was not sufficiently saturating to determine the catalytic rate, kcat, of
peptidyl transfer. This is due to the difficulty of aminoacylating tmRNA in vitro. However,
since reactant concentrations were the same between various tmRNA-SmpB complexes, we
can compare the observed peptidyl transfer rate (kobs). The rates reported here are
preliminary. The experiments are being repeated in duplicate using a lower concentration of
ribosomes and a higher concentration of tmRNA-SmpB complexes. This will increase the
overall yield of the reaction and provide a more reliable kobs.
We measured the ability of four SmpB mutants to support dipeptide formation:
D137KR:AAA, Δ153, Lys151Pro and G132K:AA. D137KR:AAA and Δ153 were previously
shown to have peptidyl transfer defects using mass spectrometry analysis.23 In our assay,
both of these mutant complexes had an observed petidyl transfer rate of less than 0.01 s–1
(Figure 2-5). This is significantly lower than the observed rate for wild-type SmpB
complexes (1.97 ± 0.15 s–1). Lys151Pro complexes formed a dipeptide at an observed rate
near 0.01 s–1, similar to D137KR:AAA and Δ153 (Figure 2-5). The slow observed rates for
these three mutants indicate that they do not support peptidyl transfer at sufficient rates to see
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Figure 2-5: Plots of dipeptide formation in stalled ribosome complexes incubated with either wildtype SmpB-tmRNA or the indicated mutant SmpB-tmRNA. The observed peptidyl transfer rate of
each reaction was determined from the initial slope of the curve. Made with GraphPad Prism 5.
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tmRNA tagging in vivo. G132K:AA complexes, however, support dipeptide formation at an
observed rate of 2.40 ± 0.21 s–1, comparable to wild-type complexes (Figure 2-5). Unlike the
other SmpB mutants tested, the G132K:AA defect in supporting tmRNA mediated tagging is
not in peptidyl transfer, but a step further downstream.
To further characterize the G132K:AA defect in trans-translation, we tested the ability
of this mutant complex to make a tripeptide. In order to make fMet-Ala-Ala, the tmRNASmpB complex must translocate to the P site and position the tmRNA open reading frame in
the A site. While we were able to make a tripeptide with wild-type SmpB-tmRNA
complexes, no tripeptide formed using a G132K:AA-tmRNA complex (data not shown).
This isolates the G132K:AA defect to either translocation to the P site or some event in
the P site that allows translation of the tmRNA open reading frame to begin. We tested for
misreading of the tmRNA open reading frame in the immunoblot assay. By moving the His6
epitope into the +1 and –1 frames, we are able to detect tagging that begins one nucleotide
away from the correct resume codon. No tagging was detected in the +1 or –1 frames
(Figure 2-6).
Figure 2-6: Immunoblot analysis of frame choice.
tmRNA-mediated tagging in the –1 and +1
frames with G132K:AA or A131GAK SmpB. Wildtype SmpB is coupled with U85A –1 tmRNA or
A86C +1 tmRNA as a control for visualizing
tagging (+).

rRNA nucleotides in the decoding center are not required for accommodation
Lysines 131 and 133 in the SmpB tail were recently implicated in interacting with the
decoding center nucleotides A1492 and A1493.31 SmpB is able to protect these and other
nucleotides in the A site from chemical modification in vitro.30, 31 We set up peptidyl transfer
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experiments to determine if any interaction of the SmpB tail with A1492 and A1493 is
functionally relevant to the first peptidyl-transfer step of trans-translation.
The mutations A1492G and A1493G reduce EF-Tu activation at least 40-fold and
tRNA accommodation 5 to 20-fold.53 In collaboration with Rachel Green’s lab, we were able
to purify ribosomes with these individual mutations and test them in the dipeptide assay.
Stalled ribosome complexes were prepared with fMet in the P site and a phenylalanine
mRNA codon in the A site. This short three-nucleotide extension does not interfere with
SmpB-tmRNA entry into the ribosome.54 The control Phe-tRNA has drastically reduced
yields of dipeptide formed in both 1492G and 1493G ribosomes compared to wild-type
ribosomes (Figure 2-7). If these nucleotides are critical to peptidyl transfer in transtranslation, we would expect to see a similar decrease in dipeptide yield when these
ribosomal mutants are paired with SmpB-tmRNA complexes. However, the dipeptide yield
with SmpB-tmRNA on mutant ribosomes was not significantly decreased compared to the
yield on wild-type ribosomes (Figure 2-7). The observed rates of these reactions are
currently being measured.

Figure 2-7: Mutant ribosomes
and
peptidyl
transfer.
Autoradiograph
image
of
electrophoresed TLC. Wild-type
or mutant ribosome complexes
were incubated with either a
Phe-tRNA or tmRNA-SmpB.
Each reaction was incubated at
37˚C for 1.5 min., 5min., or 10
min. (left to right) before quench
with KOH.
fMet-Phe runs
slightly farther than fMet-Ala.
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Discussion
In this chapter we present new information about the SmpB tail and its functional role
in trans-translation. We characterize the previously hypothesized helical structure of the
SmpB tail within the ribosome and conclude that a helix is required to support peptidyl
transfer. Lys151Pro would prevent the tail from forming a helix, and it destroys transtranslation activity in vivo as well as SmpB-mediated peptidyl transfer in vitro. Loss of the
lysine residue itself is not the problem, as Lys151Ala supports tmRNA mediated tagging as
well as wild-type SmpB. Some proline mutants do support tmRNA mediated tagging,
indicating the helical boundaries. The helix begins around Lys143 and continues to at least
Ile154. Interestingly, there appears to be some flexibility in the middle of the helix, as
tmRNA tagging with Gln148Pro is only partially reduced. Although each proline mutant
was not tested for its ability to support peptidyl transfer in vitro, we propose they all behave
similarly based on their inability to support tmRNA tagging in vivo. SmpB tail mutations
previously shown to be nonfunctional in peptidyl transfer (D137KR:AAA and ∆153) were
used throughout our work as controls. D137KR is just upstream of the helix and I154M is near
the C-terminus of the helix. Perhaps the functional purpose of the helix is positioning these
crucial residues within the A site. We note that the basicity of the tail also appears to be
important, though we do not characterize at which step in trans-translation the positive
charges are required.
We also examined the functional significance of another conserved region at the start
of the SmpB tail, K131GKK. Single mutation of each amino acid in this sequence to alanine
had no effect on tagging except for Gly132Ala, which decreased tagging two-fold. The
absence of a sidechain on glycine allows it more flexibility than other amino acids, while the
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methyl group on alanine partially constrains the allowed angles. This part of the tail could be
required to form a tight kink inside the ribosome, easily allowed by glycine and slightly
hindered by alanine. Surprisingly, combining the slightly decreased Gly132Ala mutation
with Lys133Ala eliminated all tagging. This GK mutant, K131AAK, retains two positive
charges in the area. Mutants with only one positive charge, A131GAK or K131GAA, were
able to support tagging, though at a significantly decreased levels. Removing all three
positive charges, A131GAA, eliminates tagging just as the G132K:AA mutant.
The G132K:AA mutant is different from all other SmpB mutants studied in that it
supports peptidyl transfer as well as wild-type SmpB. G132K:AA is nonfunctional due to a
defect downstream of decoding, after transfer of the stalled peptide onto tmRNA. This is a
novel function for SmpB, whose previously characterized functions were binding to tmRNA
and improving its aminoacylation, as well as associating with the ribosome and promoting
peptidyl transfer.
The G132K:AA mutant does not allow the ribosome to begin translation of the tmRNA
open reading frame. While wild-type SmpB supports formation of fMet-Ala-Ala in vitro,
G132K:AA does not. This is not due to a slight slip in selection of the resume codon: the
G132K:AA complex does not support tmRNA tagging in the 0, +1 or –1 frames. It is possible
that the open reading frame is not positioned in the mRNA tunnel at all, so the ribosome has
no recognizable template on which to resume translation. Another possibility is that
G132K:AA complexes cannot translocate from the A site to the P site. Work in our lab
continues to isolate which if either of these failings describe the G132K:AA mutant.
Specific amino acids in SmpB were recently proposed to directly interact with
ribosomal nucleotides A1492 and A1493, possibly mimicking canonical decoding to signal
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for peptidyl transfer. However, we show that an interaction between SmpB and A1492 or
A1493 is not absolutely required for peptidyl transfer. While both A1492G and A1493G
mutant ribosomes decode a Phe-tRNA with diminished efficiency, neither mutation greatly
affects SmpB-tmRNA decoding. The observed rates of these reactions are currently being
measured so that we can determine if A1492 and A1493 play a slight role in the first peptidyl
transfer event of trans-translation or if they do not contribute. This is one instance where the
trans-translation system may not mimic normal translation.
SmpB makes other contacts with the ribosomal A site which could be required for
peptidyl transfer. We propose crosslinking amino acid residues in or near DKR and IM to
the ribosome. Once ribosomal nucleotides which are near these amino acids in the A site
have been identified, they can be functionally analyzed to determine their relevance to SmpB
stimulated peptidyl transfer.
We conclude that SmpB is even more critical to the trans-translation process than
previously noted. Not only does SmpB protect tmRNA from degradation, enhance its
aminoacylation, promote its stable association with the ribosome and signal for peptidyl
transfer to occur, but it also functions after peptidyl transfer to allow translation of the
tmRNA open reading frame to begin. SmpB is involved in transitioning the ribosome from
its old mRNA template to the new tmRNA template.

Materials and Methods
Materials: Enzymes for cloning were purchased from New England Biolabs. The
mouse anti-His6 antibody was purchased from Cell Signaling Technology and the rabbit anti-
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GST antibody from Sigma. Both secondary antibodies (anti-mouse IRDye 800 and antirabbit IRDye 680) were from LI-COR Biosciences.
Immunoblot analysis of tagging – The pDH210 plasmid expresses the GST protein
with the stall-inducing sequence Glu-Pro-Stop added to the C-terminus. It also expresses
tmRNA altered to encode an ANDH6D tag. Variants of pDH210 were made that encode this
His6-containing tag only if the ribosome resumes on tmRNA in either the –1 or +1 frame, by
deleting C98 or by inserting a G immediately before G90, respectively. ∆ssrA-smpB cells
carrying pDH210 and an SmpB expression plasmid (pDH113) were grown in ampicillin and
tetracycline to an OD600 of 0.5. The expression of GST was induced with 1 mM IPTG. After
2.5 h, the cells were pelleted and lysed with SDS. Protein in the crude lysate was quantified
via Lowry assay and each sample was resolved by 10% SDS-PAGE. The protein was
transferred to PVDF membrane and His6-tagged GST was bound by a mouse anti-His6
antibody. Binding of a rabbit anti-GST antibody was used to control for protein expression
and loading. Fluorescent secondary antibodies (anti-mouse IRDye 800 and anti-rabbit IRDye
680) were added and the blot was visualized with an Odyssey Infrared Imaging System (LICOR Biosciences).
In vitro translation components – Tightly coupled 70S ribosomes were purified from
MRE600 as described previously.55 Mutant ribosomes were purified as described.53
Initiation factors and EF-Tu were purified as described previously.56, 57 tmRNA was
prepared from double-stranded DNA template using run-off transcription by T7 RNA
polymerase,58 then purified and aminoacylated as described previously for tRNAs.59
Aminoacylation and formylation of the initiator tRNAfMet with radiolabelled [35S]-methionine
using S100 extract was done as previously described.60 The aminoacylated tRNA was
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purified by phenol and chloroform extraction followed by ethanol precipitation and
resuspended in 20 mM potassium acetate buffer, pH 5.1, with 1 mM DTT. Wild-type and
mutant SmpB were overexpressed with an N-terminal His6 tag in BL21 using a pET15b
vector. The protein was purified on a Ni-NTA column.
Initiation complexes – Stalled ribosome initiation complexes were prepared by
incubating 2 µM 70S ribosomes with 6 µM mRNA (GGG AAT TCG GGC CCT TGT TAA
CAA TTA AGG AGG TAT ACT ATG TTC), 2 mM GTP, and 3 µM each IF1, IF2, IF3,
fMet-tRNA35SfMet in 1×219 buffer (50 mM Tris HCl, pH 7.5, 70 mM NH4Cl, 30 mM KCl, 7
mM MgCl2, 1 mM DTT) at 37 °C for 30 min. Following incubation a minimal amount of
MgCl2 was added to bring the final Mg2+ concentration to 10 mM. Complexes were purified
by spinning through a 1.3 mL sucrose cushion (1.1 M sucrose, 20 mM Tris-HCl, pH 7.5, 500
mM NH4Cl, 10 mM MgCl2, 0.5 mM EDTA) at 69 krpm in a TLA100.3 rotor for 2 h. The
complexes were resuspended in 1×219 buffer, aliquoted and frozen at –80°C until used.
Ternary complexes – Ternary complexes were prepared in 1×219 buffer by
incubating 2 mM GTP with either 2.5 µM tmRNA and 5 µM SmpB, or 2.5 µM Phe-tRNAPhe
at 37 °C for 2 min. Then EF-Tu (previously incubated with 2 mM GTP for 10 min at 37 °C)
was added to a final concentration of 5 µM and the complex was incubated at 37 °C for
another 5 min.
Dipeptide Assay – Immediately following incubation of the ternary complexes,
ribosome initiation complexes were added to a final concentration of 100 nM. Samples of
each reaction were quenched with 100 mM potassium hydroxide at various time points. For
faster reactions 250 mM ribosomes were added to the ternary complex in a quench-flow
instrument (RQF-3 quench-flow, KinTek Corporation). Samples were electrophoresed on
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cellulose TLC plates in pyridine-acetate pH 2.8. The fraction of dipeptide formed was
measured using ImageQuant v5.2 (Molecular Dynamics) and plotted against time. The
observed rate of dipeptide formation was determined from the initial slope of a one phase
association curve fitted to each plot in GraphPad Prism 5.
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CHAPTER 3: SMPB CONTRIBUTES TO READING FRAME SELECTION
IN THE TRANSLATION OF TMRNA

This chapter is modified from a manuscript in press: Watts, T.; Cazier, D.; Healey, D.;
Buskirk, A., SmpB Contributes to Reading Frame Selection in the Translation of TransferMessenger RNA. J Mol Biol 2009.
Introduction
Stalled ribosomes in eubacteria are rescued and recycled by a highly conserved
quality control mechanism. Ribosomes stall upon reaching the 3'-end of mRNAs that lack a
stop codon. With empty A sites, these ribosomes are trapped on the defective mRNA
because they cannot efficiently bind release factors. Instead, stalled ribosomes recruit
transfer-messenger RNA (tmRNA) and its binding partner, small protein B (SmpB) to their
empty A sites. SmpB and aminoacylated tmRNA function first as a tRNA, transferring
alanine to the nascent polypeptide. The stalled ribosome then resumes translation using
tmRNA as a template, translating a short open reading frame that encodes a proteaserecognition sequence. Through the action of tmRNA and SmpB, known as trans-translation,
the aborted polypeptides are tagged for degradation by cellular proteases and the ribosome is
released at a stop codon and recycled.14, 16, 61
As the ribosome switches templates from the defective mRNA to tmRNA, how is the
appropriate codon in tmRNA selected for translation to resume? The global structure of
tmRNA plays little role in the selection of the correct frame. The four pseudoknots that
dominate the tmRNA structure can be replaced with unrelated sequences with little or no loss
of tmRNA activity.34-36 Instead, the reading frame is chosen locally, by five bases
immediately upstream of the resume codon.37-39 Mutations in this upstream sequence
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(U85AGUC) lead to reduced tmRNA function and errors in frame selection in vitro and in
vivo. Mutation of the first two of these nucleotides is particularly deleterious: the U85A
mutation, for example, partially shifts translation to the –1 frame.39 Mutation of the
universally conserved A86 leads to severe loss of function:37, 39 the A86C mutation shifts
translation entirely to the +1 frame in vivo.38 From these data, we proposed that the resume
codon is chosen by its placement in the ribosome as determined by the binding of an
unidentified ligand to A86.38
A variety of candidates have been reported to bind the sequence upstream of the
resume codon. One suggestion is that the last of these upstream nucleotides, the so called –1
triplet (G87UC), is recognized directly by rRNA in the ribosomal decoding center,41 although
this hypothesis does not withstand analysis of tmRNA activity in vivo.38 Another candidate
is ribosomal protein S1, previously shown to crosslink to U85.42 Cryo-electron microscopy
structures of tmRNA bound inside 70S ribosomes reveal that S1 affects the structure of the
tmRNA template sequence.43 Though S1 cannot interact directly with tmRNA on the
ribosome, it has been proposed that free S1 binds tmRNA and stabilizes a functional, open
complex that is then passed to stalled ribosomes.43 In support of this model, one study
presents evidence that S1 is required for tmRNA to serve as a template in vitro.46 There are
also reports that refute this proposed role for S1, however, using reconstituted translation
systems44, 45 as well as in vivo functional analysis.47
Another promising candidate is SmpB, a protein that plays a role in the stability and
aminoacylation of tmRNA and is required for its entry into the ribosome. SmpB binds the
tRNA-like domain (TLD) of tmRNA in a well-characterized interaction.27 Interest in SmpB
has focused on its ability to license tmRNA entry into the ribosomal A site through
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interacting with the decoding center.23, 32 Recent reports suggest that more than one binding
site for SmpB exists in tmRNA, raising the possibility of additional functions for this protein.
Felden and co-workers showed that SmpB binding reduces the accessibility of the upstream
sequence to nucleases in probing assays and proposed that SmpB plays a role in resume
codon selection.49 After further characterization with surface plasmon resonance and filter
binding assays, they report that this interaction is higher in affinity than SmpB binding to the
TLD.51 An interaction between SmpB and the upstream region was likewise reported by
Himeno and co-workers using chemical probing assays. Intriguingly, the site of SmpB
binding shifted in tmRNA mutants known to alter the frame in which translation resumes.48
On the other hand, several crosslinking and chemical probing assays have failed to detect an
interaction between SmpB and the tmRNA upstream sequence.19, 50, 62
The role of S1 and SmpB in frame selection remains controversial because binding
has only been detected in some assays in vitro and these RNA-protein binding events have
not been shown to affect tmRNA activity either in vitro or in vivo. To test for a functional
interaction between SmpB and the upstream region of tmRNA, we identified mutations in
SmpB that restore the function of an A86C mutant tmRNA. This mutation strongly reduces
tmRNA activity in several assays and causes tmRNA to be translated exclusively in the +1
frame.38 Several SmpB mutations were identified which rescue tmRNA function and alter
frame selection on A86C tmRNA. These results demonstrate definitively that SmpB plays a
biologically relevant role in setting the frame on tmRNA.
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Results
SmpB mutations restore A86C tmRNA function
We used a genetic selection to identify mutations in SmpB that suppress the defect
(improper frame selection) in A86C tmRNA. The selection relies on the tmRNA tagging
process to complete the synthesis of the kanamycin resistance protein (KanR).35, 38
Ribosomes are programmed to stall at the end of a truncated KanR protein that lacks the Cterminal 15 amino acids. tmRNA rescues these stalled ribosomes and tags the nascent
polypeptide with the missing 15 amino acids; these are encoded by an altered tmRNA
template sequence. In this way, tmRNA function completes the KanR protein and makes the
cells kanamycin resistant (Figure 3-1). While cells with wild-type (A86) tmRNA survive
equally well with or without kanamycin, only about 1 in 106 cells expressing the A86C
tmRNA mutant form colonies on selective media, even at the lowest stringency conditions
(15 µg/mL kanamycin at 25°C). This low background survival rate allowed us to select for

Figure 3-1: Genetic selection for SmpB mutants that restore A86C tmRNA activity. Translation of a
truncated KanR gene is stalled during termination at the sequence Glu-Pro-Stop. The resulting KanR
protein lacks the C-terminal 15 amino acids (red) and is inactive unless these stalled ribosomes are
rescued by tmRNA that has been altered to encode the last 14 amino acids, ANKLQFHLMLDEFF.
8
Roughly 10 SmpB mutants were screened to identify those that restore tagging levels sufficient to
synthesize KanR and confer cellular survival on kanamycin plates.
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SmpB mutants that suppress the A86C defect and restore high levels of tmRNA function and
kanamycin resistance.
We generated a library of ~108 SmpB mutants using error-prone PCR and subjected it
to the KanR selection with A86C tmRNA, obtaining survival levels 100-fold higher than
background. The SmpB genes were recloned from this enriched pool and reselected, with
nearly all the cells surviving on selective plates. Sequencing revealed three related but
distinct SmpB clones that were designated A1, A2 and A5 (Table 3-1). The A1 clone has
two changes, Tyr24Cys and Val129Ala. A2 has these and the additional Glu107Val
mutation. A5 shares the same Tyr24Cys mutation as A1 and A2 but coupled instead with
Ala130Gly. The tagging activity of these three SmpB clones was measured by plating cells
Clone
A1
A2
A5

SmpB mutations
Tyr24Cys
Val129Ala
Tyr24Cys Glu107Val Val129Ala
Tyr24Cys
Ala130Gly

Table 3-1: SmpB clones that restore A86C tmRNA activity. Changes in the
SmpB sequence are shown for three clones that survived the KanR
selection for tmRNA activity. The codons for the Tyr24Cys and Val129Ala
mutations are the same at the DNA level in each clone that they appear.

on media containing 15
µg/mL kanamycin at 25 °C.
A1 conveyed 50% survival
while A2 and A5 both
conveyed ~90% survival,

several orders of magnitude higher than the background level of 1 in 106. These findings
show that mutations in SmpB can compensate for deficiencies in the function of the upstream
region of tmRNA and the critical nucleotide A86 in particular.

SmpB mutations affect frame choice on A86C tmRNA
To verify that the selected SmpB mutants restore tmRNA activity, we directly
measured the tmRNA tagging levels with immunoblots. In the immunoblot assay, tmRNA
directs the addition of a His6 tag to the end of the full-length GST protein. The sequence
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Figure 3-2: Sequence and structure of
tmRNA. A) Secondary structure of E. coli
tmRNA, including the tRNA-like domain
(TLD), four pseudoknots (PK1-4), and the
resume and stop codons boxed at either end
of the tag template sequence. B) Fragment
of the tmRNA sequence including the first
five codons in the tag template as well as
five nucleotides of the upstream sequence
known to play a role in frame selection. The
resume codon is underlined. The His 0
template encodes ANDH6D in the natural
frame; addition of a G before G90 leads to
the synthesis of this tag only when the +1
frame is read in the His +1 reporter.
Likewise, deletion of C98 leads to synthesis
of RKRH6D only upon translation in the –1
frame in the His –1 reporter.

Glu-Pro-Opal was used at the Cterminus of GST to induce stalling
during termination.13 The tmRNA
template sequence was altered to encode
ANDH6D. Tagging in the natural (or 0)
frame was detected by immunoblot
using an anti-His6 antibody. We also
developed additional tools to detect
translation of the tmRNA template in
other frames.38 We created a +1 frame construct by inserting a single G before G90, the first
nucleotide in the resume codon. This tmRNA encodes a His6-tag only if tmRNA is translated
in the +1 frame. Likewise, tmRNA in which C98 is deleted only encodes the His6-tag when
read in the –1 frame (Figure 3-2). These three tmRNA constructs allow tagging in all three
frames (–1, 0, +1) to be visualized on an immunoblot for any given tmRNA and SmpB
mutant pair.
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Wild-type SmpB yields no detectable activity in the 0 frame and high levels of +1
frame tagging with A86C tmRNA (Figure 3-3 A). In contrast, the selected A1, A2, and A5
SmpB clones all restore significant levels of tagging in the 0 frame; the A2 mutant is the
most active. The A2 mutant also reduces the +1 frame tagging seen with wild-type SmpB (ttest P < 0.01). It appears that the total level of tagging remains constant in the A2 mutant—
tagging in the +1 frame decreases at about the same level as tagging in the 0 frame increases
(Figure 3-3B). No significant reduction of +1 frame tagging was detected with A1 or A5, but
this is expected since these mutants restore 0 frame tagging at lower levels. No tagging in
the –1 frame was detected with the wild-type or mutant SmpB clones (data not shown).
U85A tmRNA was used as a control to verify that tagging in the –1 frame could be
visualized. The restoration of tagging in the natural frame and reduction in the +1 frame

Figure 3-3: SmpB mutants alter frame selection on A86C tmRNA but not wild-type tmRNA. A)
Tagging by A86C tmRNA with the selected SmpB clones. B) Quantification of the level of A86C
tmRNA tagging divided by the level of GST expression, normalized to the level of +1 tagging with
wild-type SmpB. Error bars report the standard deviation of three independent experiments. C)
Tagging by wild-type tmRNA (A86) in all three frames in combination with various SmpB alleles.
A86C and U85A were used as positive controls for the detection of +1 and –1 frame tagging,
respectively, with wild-type SmpB (the + lanes).
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suggests that these SmpB mutants rescue tmRNA function in the KanR selection by restoring
the proper reading frame on A86C tmRNA. These data corroborate the genetic findings that
SmpB is functionally tied to the upstream region of tmRNA. They also provide evidence that
SmpB plays a role in selection of the reading frame.

Analysis of the role of the selected mutations in restoring tagging
How do these SmpB mutants alter frame selection and restore function? Our model
of frame selection relies on two interactions: the known binding of SmpB to the ribosomal P
site30, 50 and the controversial binding of SmpB to the upstream sequence of tmRNA.
Altering either of these could potentially restore function to A86C tmRNA. If the selected
mutants act by repositioning SmpB in the ribosome, then they should act in a dominant
manner, altering frame selection on any tmRNA, not just A86C tmRNA. To test this
hypothesis, we analyzed reading frame selection with SmpB clones A1, A2, and A5 with
wild-type (A86) tmRNA. Immunoblot analysis revealed no evidence of increased translation
in either the +1 or –1 frame (Figure 3-3 C). This result shows that our SmpB mutants are not
sufficient to alter frame recognition alone—they only do so in the context of the A86C
mutation. This suggests that they act by restoring the interaction of SmpB with the tmRNA
upstream sequence.
How is the binding to the upstream sequence on tmRNA restored? Perhaps the
interaction with A86 that was lost was compensated for by a new interaction with C86. Are
the selected SmpB clones specific for C86 or do they support tmRNA activity with the wildtype tmRNA? Immunoblot analysis with A86 tmRNA revealed that the mutants show no
loss of function in the normal frame (Figure 3-3 C). We also tested the A1, A2, and A5
clones in the KanR assay against A86 tmRNA encoding the KanR tag; the SmpB mutants did
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not lower the level of survival. These findings indicate that specificity for the tmRNA
upstream sequence was relaxed to allow either adenosine or cytidine at position 86, rather
than altered to be specific for the cytidine nucleotide. Relaxed specificity is the simpler
solution in most cases; in directed evolution experiments a negative selection against the
wild-type sequence must be used to obtain truly altered specificity.63
What is the role of each amino acid change in the selected SmpB clones? The
Tyr24Cys mutation appears in all three (Table 3-1). To test if the cysteine side chain was
functionally important, we replaced the Tyr24Cys mutation with Tyr24Ala in A2. The
resulting SmpB protein supported survival levels similar to the original A2 mutant in the
KanR assay, suggesting that Tyr24Cys is a loss-of-function mutation. Replacing the large
tyrosine side chain with a smaller amino acid is sufficient. In contrast, the Glu107Val
mutation found in A2 appears to be a gain of function mutation. The A2 clone is the most
active of the three selected mutants, with the greatest increase in 0 frame tagging. The only
difference between A1 and A2 is that A2 also has the Glu107Val mutation. Perhaps the large
Val side chain provides a site for a hydrophobic interaction.
Which mutations are necessary for altered function and how do they work together?
We tested all four mutations found in the three selected clones both individually and in pairs.
The following mutants were assayed by immunoblot with A86C tmRNA: the single
mutations Y24C, E107V, V129A, A130G, and double mutations Y24C/E107V,
E107V/V129A, E107V/A130G, and V129A/A130G. None of these yielded a detectable
amount of tagging in the 0 frame (data not shown), in contrast to the substantial signals seen
with the original pairings. We conclude that at least two mutations are required to rescue
A86C tmRNA: Tyr24Cys and either Val129Ala or Ala130Gly.
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When mapped onto the atomic structure of Thermus thermophilus SmpB,27 these
three residues cluster in a junction at the bottom of the protein, at the opposite end from the
well-characterized tmRNA binding site (Figure 3-4 A). This junction is formed from the
beginning of the C-terminal tail and loops linked to helices 1 and 3. The fourth selected
mutation, Glu107Val, is found nearby in the loop following helix 3. The clustering of these
smutations in this single site implicates this junction at the bottom of SmpB in the frame
selection process.
The Tyr24 side chain makes
hydrophobic interactions with several other
residues in this junction region. We
introduced mutations to test the importance
of these hydrophobic interactions in the
natural function of the SmpB protein (i.e.
paired with wild-type A86 tmRNA).
Replacement of Tyr24 with charged residues
Glu or Arg results in a complete loss of

Figure 3-4: Structure and mutagenesis of SmpB. A)
The structure of the SmpB-tmRNA complex from T.
thermophilus is shown with the tRNA-like domain of
tmRNA in orange and SmpB in blue(Bessho, 2007).
Residues mutated in the selected SmpB clones are
shown in red. The first three amino acids in the Cterminal tail (K131GK) are shown in yellow. Residue
labels depict the E. coli numbering and sequence.
Created with Pymol. B) Tagging of stalled GST
was measured by immunoblot as in Fig. 3-2 but
with wild-type (A86) tmRNA encoding ANDH6D in
the natural (0) frame. This series of SmpB mutants
was designed to test the structural role of residues
at the junction where the C-terminal tail begins.
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SmpB function (Figure 3-3B), while mutation to Leu is well tolerated. Mutation to the
smaller side chains Cys or Ala also has little or no effect on SmpB activity. Analysis of the
atomic structure likewise suggests that the Ala130 side chain interacts with Tyr24. Mutation
of Ala130 to the charged Glu or the bulky Leu dramatically reduce SmpB function (Figure 33B). Deletion of Ala130, effectively replacing it with Lys131, likewise destroys SmpB
function. These mutagenesis results support the conclusion that Tyr24 and Ala130 form
hydrophobic interactions that are essential for SmpB activity. This junction region has to be
fine-tuned carefully to avoid disrupting these key interactions. Immunoblot analysis reveals
that none of the selected mutations alone inhibit SmpB activity on A86 tmRNA (Figure 33B). We propose that the Tyr24Cys, Val129Ala, and Ala130Gly mutations identified in our
selection introduce structural plasticity into this junction region, and suggest that this is what
allows these SmpB mutants to interact productively with both A86 and A86C tmRNA.

Discussion
Our findings demonstrate that SmpB and the region upstream of the resume codon on
tmRNA are functionally linked; both play a role in establishing the reading frame on
tmRNA. The A86C mutation in tmRNA leads to the total loss of 0 frame tagging and high
levels of +1 frame tagging. We identified several SmpB mutants that restore the function of
A86C tmRNA both in a genetic selection and in a direct assay for the addition of the tmRNA
tag. The A2 mutant restores 0 frame tagging at about the same level that it reduces +1 frame
tagging (Figure 3-3 B). This suggests that the overall tagging efficiency is the same and that
A2 increases tmRNA activity by simply restoring the proper frame in tmRNA translation.
Interestingly, the mutant SmpB clones do not alter frame selection on wild-type (A86)
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tmRNA. As the SmpB mutants act with specificity (only on A86C tmRNA) in reorienting
frame choice, we conclude that they restore the interaction between SmpB and the upstream
sequence.
How might SmpB set the frame during trans-translation? SmpB binds to the tRNAlike domain of tmRNA to form a structure that mimics normal tRNAs.27 SmpB serves as the
anticodon stem of this structure and licenses entry of the SmpB-tmRNA complex into the
ribosomal A site. Following accommodation and peptidyl transfer, this complex moves to
the P site.50, 64 SmpB binds the 30S P site with high affinity even without tmRNA.29, 30 We
envision a model in which interactions with the P site position SmpB precisely such that its
draws tmRNA into the A site (Figure 3-5). With the first codon (GCA) lying in the mRNA
channel in the decoding center, translation begins with tmRNA as a template. Intriguingly,
the SmpB residues identified in our selection as affecting frame selection (Tyr24, Val129,
and Ala130) cluster together in
a hydrophobic pocket located
on what would be the A-site
face of SmpB. We propose
that these mutations act
together to alter the structure of
this pocket, allowing SmpB to
Figure 3-5: Model of tmRNA frame positioning. Following
translocation, SmpB (purple) interactions with the upstream
region of tmRNA (orange) position the resume codon, GCA, in
the ribosomal A site. Figure made by Hilary Johnson.

bind the upstream region of
either A86 or A86C tmRNA.

The SmpB tail, beginning with K131GKK, emerges from this hydrophobic pocket.
Mutating K131GKK to K131AAK abolishes tmRNA-mediated tagging due to an SmpB
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supported event following peptidyl transfer but before translation of the tmRNA open
reading frame begins. Positioning the tmRNA resume codon in the A site is a major event
during this window. Although there is no evidence that GK directly binds the upstream
tmRNA region, the G132K:AA defect is further evidence that the junction at the bottom of
SmpB is involved in allowing translation of the tmRNA open reading frame to begin
following the first peptidyl transfer event. Future investigations into the GK region will
involve crosslinking these amino acids to tmRNA.

Materials and Methods
Materials – Enzymes for cloning were purchased from New England Biolabs.
MegaX DH10B electrocompetent cells were purchased from Invitrogen. The mouse antiHis6 antibody was purchased from Cell Signaling Technology and the rabbit anti-GST
antibody from Sigma. Both secondary antibodies (anti-mouse IRDye 800 and anti-rabbit
IRDye 680) were from LI-COR Biosciences.
SmpB Library Construction – The selection plasmid expresses the ssrA, smpB, and
truncated kanR genes35 and conveys resistance to chloramphenicol and ampicillin. From an
arabinose-inducible promoter, this plasmid expresses a truncated KanR protein lacking the Cterminal 15 amino acids, with the sequence Glu-Pro-Stop added to the C-terminus to induce
ribosome stalling. The ssrA tag template sequence was altered to encode the last 14 amino
acids of the kanamycin resistance protein (KanR), ANKLQFHLMLDEFF, instead of the
normal degradation tag, ANDENYALAA. The ssrA gene also contains the A86C mutation.
EagI and EcoRV cloning sites in the selection plasmid were used to insert the SmpB gene
mutagenized by error-prone PCR65 with the following primers: 392,
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GGTATCAACAGGGACACCAGG and 470, CCAGTCACGTAGCGAAGATC. The SmpB
library was introduced into MegaX DH10B competent cells by electroporation and was
amplified, purified, and then introduced into the ΔssrA-smpB strain (a gift from Brice
Felden66) for selection in the KanR assay.
KanR assay for tmRNA activity – ΔssrA-smpB cells expressing A86C tmRNA and
SmpB from the selection plasmid were grown overnight in 2xYT with ampicillin. Saturated
cultures were diluted to an OD600 of approximately 0.3 in fresh media containing 2%
arabinose and grown for 4 hours to induce expression of the KanR protein. The cells were
plated onto selective media: 2xYT, ampicillin, chloramphenicol, 2% arabinose, and 15
µg/mL kanamycin. Growth comparisons (selective vs. non-selective plates) were made after
incubation for 48 h at 25 °C. Mutant smpB genes from selected clones were amplified by
PCR and cloned into fresh selection vector and re-introduced into the selection strain to
verify their phenotype.
Immunoblot analysis of tagging – The pDH210 plasmid expresses the GST protein
with the stall-inducing sequence Glu-Pro-Stop added to the C-terminus. It also expresses
tmRNA altered to encode an ANDH6D tag. Variants of pDH210 were made that encode this
His6-containing tag only if the ribosome resumes on tmRNA in either the –1 or +1 frame, by
deleting C98 or by inserting a G immediately before G90, respectively. ΔssrA-smpB cells
carrying pDH210 and an SmpB expression plasmid (pDH113) were grown in ampicillin and
tetracycline to an OD600 of 0.5. The expression of GST was induced with 1 mM IPTG. After
2.5 h, the cells were pelleted and lysed with SDS. Protein in the crude lysate was quantified
via Lowry assay and each sample was resolved by 10% SDS-PAGE. The protein was
transferred to PVDF membrane and His6-tagged GST was bound by a mouse anti-His6
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antibody. Binding of a rabbit anti-GST antibody was used to control for protein expression
and loading. Fluorescent secondary antibodies (anti-mouse IRDye 800 and anti-rabbit IRDye
680) were added and the blot was visualized with an Odyssey Infrared Imaging System (LICOR Biosciences).
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